MedPath
NMPA Approval

Loxoprofen Sodium Oral Solution

国药准字H20254023

April 30, 2025

Drug Information

洛索洛芬钠口服溶液

口服溶液剂

10ml:60mg(按C₁₅H₁₇NaO₃计)

化学药品

April 30, 2025

Company Information

Applicant Company

海南省海口市保税区南海大道100号美国工业村3号厂房一层3-6号

Manufacturing Company

南京市江北新区科创大道18号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

洛索洛芬钠口服溶液 - NMPA 批准文号 | MedPath